Platelet rich plasma and recurrent implantation failure

Not Applicable

Recruiting

• Conditions: recurrent implantation failure.; Female infertility, unspecified; N97.9

• Registration Number: IRCT20080831001141N37
• Lead Sponsor: ROYAN Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Infertile women with a history of recurrent implantation failure
Age 20-40 years
Body Mass Index 19-29 Kg/m2
Having at least three good quality embryos

Exclusion Criteria

Women with hematologic and autoimmune disorders
Couples with chromosomal and genetic abnormalities
Women with uterine anomalies
Women with uterine and ovaries surgical history
Women with endometriosis and adenomyosis
Women with hydrosalpinx
Women with uterine fibroids
Women with recurrent abortion history
Cervicitis
History of fever condition (in up to 2 weeks before the intervention)
Use of corticosteroids (in up to 2 weeks before the intervention) or non-steroid anti-inflammatories (in up to 48 hours before the intervention)
Anemia, thrombocytopenia, platelet dysfunction syndrome, hypofibrinogenemia
Septicemia, active infections with Pseudomonas, Klebsiella or Enterococcus
History of cancer

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ive birth rate; live birth is defined in which a live fetus is delivered beyond 20 completed weeks of gestational. Timepoint: Only once; at least 20 weeks after embryo transfer. Method of measurement: Clinical information.